Skip to main content
. 2023 Jan 26;58(6):544–548. doi: 10.1177/00185787221150921

Table 1.

Adverse Reactions (≥4% Incidence) Reported in the CONFIRM Trial. 1

Adverse reaction Terlipressin (n = 200) (%) Placebo (n = 99) (%)
Abdominal pain 19.5 6.1
Nausea 16 10.1
Respiratory failure 15.5 7.1
Diarrhea 13 7.1
Dyspnea 12.5 5.1
Fluid overload 8.5 3
Pleural effusion 5.5 0
Sepsis 5.5 1
Bradycardia 5 0
Ischemia-related events 4.5 0